"Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer." by Helga Weber

Article

Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.

Oncotarget (2017)

Helga Weber, University of La Frontera
José R. Valbuena, Pontifical Catholic University of Chile
Mustafa Ahmed Barbhuiya, Johns Hopkins University
Stefan Stein, Georg-Speyer-Haus
Hana Kunkel, Georg-Speyer-Haus
Patricia García, Pontifical Catholic University of Chile
Carolina Bizama, Pontifical Catholic University of Chile
Ismael Riquelme, University of La Frontera
Jaime A. Espinoza, Karolinska Institutet
Stephen E. Kurtz, Oregon Health & Science University
Jeffrey W. Tyner, Oregon Health & Science University
Juan Francisco Calderon, Universidad del Desarrollo
Alejandro H. Corvalán, Pontifical Catholic University of Chile
Manuel Grez, Georg-Speyer-Haus
Akhilesh Pandey, Johns Hopkins University School of Medicine
Pamela Leal-Rojas, University of La Frontera
Juan Carlos Roa, Pontifical Catholic University of Chile

Link

Disciplines

Publication Date

February 16, 2017

DOI

10.18632/ONCOTARGET.15410

Citation Information

Helga Weber, José R. Valbuena, Mustafa Ahmed Barbhuiya, Stefan Stein, et al.. "Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer." Oncotarget Vol. 8 Iss. 16 (2017) p. 26169 - 26184
Available at: http://works.bepress.com/mustafa-barbhuiya/18/